SPOTLIGHT: FiercePharma's Top 10 Articles of 2007

Since FiercePharma was launched in August we've published hundreds of articles, but there are some that are clear favorites with our readers. Check out this list of our most read articles in 2007 to find out which reports FiercePharma readers liked best. List

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.